Skip to content
Riskpilot
← Back to search
Sign in
Get full access
SibbarPharma AB
AB
Active
Org 5590038906
Skånegatan 20, 216 11
Limhamn
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2015
0 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
SibbarPharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
EA
Eva Anna Katarina Lindberg
Chief Executive Officer
Chief Executive Officer
2022
Former (1)
BA
Bengt Arne Lindberg
Chief Executive Officer
Chief Executive Officer
2020 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
EE
Erik Ernst Hubert Lindberg
Deputy Board Member
2020
KA
Karin Anna Lovisa Lindberg
Board of Directors
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on SibbarPharma AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network